Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season
HOUSTON, Texas, Nov. 26, 2025 — As the holiday season approaches, gatherings among family and friends are expected to increase the risk of respiratory virus transmission, including COVID-19 and influenza. In response, Healgen® Scientific highlights the Rapid Check® COVID-19/Flu A&B Antigen Test, a 3-in-1 at-home rapid test designed to help users quickly distinguish between COVID-19 and common flu viruses.
According to the U.S. Centers for Disease Control and Prevention (CDC), the 2025–2026 respiratory disease season is expected to result in a comparable level of hospitalizations for COVID-19, influenza and RSV as last year’s peak. With public gatherings and family travel increasing from Thanksgiving through New Year’s, the ability to accurately identify the source of symptoms at home is essential for preventing household transmission and ensuring timely care.
“During peak respiratory seasons, identifying the cause of illness quickly is the first step to taking the right action,” said Dr. Bingliang Fang, CEO of Healgen Scientific. “Our combo rapid test addresses a critical gap in clinical diagnostics by providing a reliable and user-friendly solution for individuals to test themselves at home. Early diagnosis enables faster initiation of appropriate treatment, leading to improved health outcomes and reduced disease transmission.”
Reliable results in minutes: Healgen Rapid Check® COVID-19/Flu A&B Antigen Test
Healgen Rapid Check® COVID-19/Flu A&B Antigen Test offers the following key features:
- 3-in-1 detection: Simultaneously identifies COVID-19, Influenza A and Influenza B so users can determine the likely cause of symptoms with a single test.
- Fast results: Provides reliable results in about 15 minutes through a dual-window design for straightforward interpretation.
- Easy sampling: Uses a shallow anterior nasal swab suitable for individuals aged 2 and older, making it comfortable and accessible for families.
- Clinical performance: FDA-reviewed clinical data in symptomatic individuals showed the test correctly identified 99% of negative and 92% of positive SARS-CoV-2 samples; 99.9% of negative Flu A and B samples; and 92.5% and 90.5% of positive Flu A and Flu B samples, respectively. (Source: U.S. FDA)
The Healgen Rapid Check® COVID-19/Flu A&B Antigen Test provides consumers with a practical tool to manage health at home, removing uncertainty between common cold, flu and COVID-like symptoms so families can make timely care decisions during travel and gathering seasons.
About Healgen
Founded in 2007 in Houston, Texas, Healgen Scientific is a global in-vitro diagnostics (IVD) developer and manufacturer focused on advancing healthcare through innovative and reliable testing technologies. Its portfolio includes infectious disease, toxicology and molecular diagnostics products that support healthcare providers and communities worldwide. For more information, visit Healgen’s official website.
SOURCE: Healgen Scientific